Independent and functional validation of a multi-tumour-type proliferation signature
Open Access
- 21 June 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 107 (3), 508-515
- https://doi.org/10.1038/bjc.2012.269
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerNature Medicine, 2010
- Genes that mediate breast cancer metastasis to the brainNature, 2009
- Inhibition of 4E-BP1 Sensitizes U87 Glioblastoma Xenograft Tumors to Irradiation by Decreasing Hypoxia ToleranceInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer typesBritish Journal of Cancer, 2008
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation studyNature Medicine, 2008
- Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomasInternational Journal of Cancer, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Common markers of proliferationNature Reviews Cancer, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002